Catheter study for lung blood clots pulled before it started
NCT ID NCT06975969
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study was designed to test a special catheter that delivers clot-dissolving medicine directly into the lungs of people with blood clots. The trial was withdrawn before enrolling any participants, so no results are available. It would have included adults aged 18 to 80 with submassive pulmonary embolism.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Versus™ Endovascular Pulmonary Artery Drug Delivery Catheter
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BLOOD CLOTS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Virginia Medical Center
Charlottesville, Virginia, 22903, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a phone app replace cardiac rehab? a new trial puts digital heart care to the test
- Bedside flu shot for heart patients: a simple strategy to save lives?
- Can an immunotherapy cocktail shrink inoperable lung tumors?
- Zapping lung nerves could ease heart Failure-Related high blood pressure
- Heart caregivers get a lifeline: coaching program aims to ease stress and boost mental health
- Decades-Long study of 121,700 nurses aims to uncover hidden heart disease triggers